BSM(SZ:300796)2025-01-23 10:50Financial Performance Expectations - The company expects a net loss attributable to shareholders of between 24 million and 37 million RMB for the year 2024, compared to a profit of 88.41 million RMB in 2023[3] - The net loss after deducting non-recurring gains and losses is projected to be between 27 million and 40 million RMB, down from a profit of 84.64 million RMB in the previous year[3] Operational Challenges - The loss is primarily attributed to the subsidiary Tongling Baismei Technology Co., which is in the trial production phase of its 8,500-ton annual capacity ketone series green materials project, leading to high fixed costs and low gross margins[5] - The company is experiencing a destocking cycle for its dimethyl pentyl and pesticide intermediates, resulting in reduced revenue and profit margins due to weak downstream demand[6] Future Outlook - The ketone production facility is expected to stabilize by the end of Q4 2024, with product quality meeting expectations and sales conditions improving[5]